Jim Simons's position in Entrada Therapeutics is currently worth $966k. That's 0.00% of their equity portfolio (2178th largest holding). The first Entrada Therapeutics trade was made in Q4 2021. Since then Jim Simons bought shares six more times and sold shares on five occasions. The investor's estimated purchase price is $2.06M, resulting in a loss of 53%.